Skip to main navigation Skip to search Skip to main content

Alzheimer’s: A progressive brain disease: Causes, symptoms, and prevention

  • Fakhra Amin
  • , Anas Shamsi
  • , Muhammad Nadeem Asghar
  • , Peerzada Shariq Shaheen Khaki
  • , Mohd Shahnawaz Khan
  • , Shams Tabrez
  • , Syed Kashif Zaidi
  • , Wajihullah Khan
  • , Bilqees Bano
  • Aligarh Muslim University
  • Université du Québec à Trois-Rivières
  • King Saud University
  • King Fahd Medical Research Center
  • Faculty of Applied Medical Sciences, King Abdulaziz University
  • King Abdulaziz University

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

9 Scopus citations

Abstract

Alzheimer’s disease (AD) is an irretrievable, mysterious, and devastating neurodegenerative disorder that leads to memory loss and impaired cognitive function. Specifically, AD patients suffer from poor thinking skills and lack potential to perform simple activities. Dementia is multifactorial disorder and considered as the main cause of AD. Alzheimer’s disease is characterized by the presence of large quantities of two remarkable structures, i.e., amyloid plaques and neurofibrillary tangles which are the hallmarks of AD. Both of these structures are misfolded proteins and thought to play an important role in the degeneracy of neurons, ultimately leading to most of AD symptoms. Another common feature of AD is the wrecking of intracellular connections which results in reduced cell function and cell death. Neurofibrillary tangles are twisted fibers which are found inside the neurons and are produced by hyperphosphorylation of a microtubule-associated protein, i.e., tau. Smoking and obesity are the putative risk factors for dementia and cardiovascular disease. Deficiency of vitamins, especially thiamine (B1), riboflavin (B2), niacin (B3), pyridoxine (B6), folate (B9), and cobalamin (B12), is associated with cognitive dysfunction and AD. Type-2 diabetes (T2D) and prediabetic insulin resistance have also been suggested as the risk factors for cerebrovascular injury and cognitive decline, eventually leading to dementia. Cognitive impairment in T2D is caused by deposits of amylin, an amyloidogenic hormone synthesized and cosecreted with insulin by pancreatic β-cells. The menace of AD can be lowered down by certain anti-inflammatory drugs, proper intake of vitamin B, nurturing physical and leisure activities. In addition, AD can also be controlled by decreasing the candidate risk factors for cardiovascular disease. Anti-amyloid approaches such as vaccination may provide a promising tool to establish safer therapeutic approaches.

Original languageEnglish
Title of host publicationBiological, Diagnostic and Therapeutic Advances in Alzheimer's Disease
Subtitle of host publicationNon-Pharmacological Therapies for Alzheimer's Disease
PublisherSpringer Singapore
Pages31-51
Number of pages21
ISBN (Electronic)9789811396366
ISBN (Print)9789811396359
DOIs
StatePublished - 1 Jan 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Alzheimer’s dementia
  • Amyloid plague
  • Neurofibrillary tangles
  • Tau proteins

Fingerprint

Dive into the research topics of 'Alzheimer’s: A progressive brain disease: Causes, symptoms, and prevention'. Together they form a unique fingerprint.

Cite this